GW&K Investment Management’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48K Sell
370
-175
-32% -$25.2K ﹤0.01% 570
2025
Q4
$78K Sell
545
-6
-1% -$804 ﹤0.01% 480
2025
Q3
$66K Sell
551
-12
-2% -$1.52K ﹤0.01% 492
2025
Q2
$74K Sell
563
-77,238
-99% -$10.5M ﹤0.01% 453
2025
Q1
$10.8M Sell
77,801
-2,300
-3% -$357K 0.1% 248
2024
Q4
$12.4M Sell
80,101
-80,277
-50% -$13.6M 0.11% 251
2024
Q3
$29.2M Sell
160,378
-3,155
-2% -$467K 0.25% 166
2024
Q2
$19.4M Sell
163,533
-2,458
-1% -$259K 0.18% 197
2024
Q1
$17.8M Buy
165,991
+3,767
+2% +$375K 0.16% 203
2023
Q4
$16.2M Sell
162,224
-16,415
-9% -$1.61M 0.15% 201
2023
Q3
$21.3M Buy
178,639
+559
+0.3% +$83.4K 0.21% 174
2023
Q2
$31.7M Sell
178,080
-1,828
-1% -$335K 0.3% 140
2023
Q1
$29.7M Buy
179,908
+2,484
+1% +$427K 0.29% 148
2022
Q4
$27.9M Sell
177,424
-3,208
-2% -$488K 0.28% 151
2022
Q3
$27.2M Sell
180,632
-5,931
-3% -$987K 0.3% 145
2022
Q2
$30.7M Buy
186,563
+8,257
+5% +$1.59M 0.33% 137
2022
Q1
$39.7M Buy
178,306
+55,679
+45% +$12.5M 0.35% 129
2021
Q4
$29.1M Sell
122,627
-1,146
-0.9% -$268K 0.24% 164
2021
Q3
$28.9M Sell
123,773
-631
-0.5% -$132K 0.26% 159
2021
Q2
$25.6M Sell
124,404
-229
-0.2% -$47.1K 0.22% 181
2021
Q1
$25.6M Buy
124,633
+631
+0.5% +$133K 0.24% 174
2020
Q4
$26.6M Sell
124,002
-68,604
-36% -$13.3M 0.28% 161
2020
Q3
$35.2M Sell
192,606
-65,302
-25% -$12.3M 0.46% 81
2020
Q2
$47.5M Sell
257,908
-93,635
-27% -$18.6M 0.67% 32
2020
Q1
$70.9M Buy
351,543
+15,424
+5% +$2.97M 1.25% 3
2019
Q4
$62.9M Sell
336,119
-11,361
-3% -$1.96M 0.84% 21
2019
Q3
$55.5M Sell
347,480
-48,596
-12% -$9.67M 0.78% 25
2019
Q2
$99.8M Sell
396,076
-7,378
-2% -$1.71M 1.51% 1
2019
Q1
$96.6M Sell
403,454
-8,896
-2% -$2.13M 1.56% 2
2018
Q4
$94.7M Sell
412,350
-8,434
-2% -$2.08M 1.87% 1
2018
Q3
$119M Sell
420,784
-108
-0% -$31.6K 1.91% 1
2018
Q2
$124M Sell
420,892
-39,691
-9% -$10.8M 2.02% 1
2018
Q1
$116M Buy
460,583
+8,324
+2% +$1.96M 1.96% 1
2017
Q4
$97.7M Sell
452,259
-43,000
-9% -$8.7M 1.67% 1
2017
Q3
$92M Sell
495,259
-438
-0.1% -$76.4K 1.53% 2
2017
Q2
$85.5M Buy
495,697
+12,808
+3% +$2.05M 1.48% 4
2017
Q1
$73.7M Sell
482,889
-8,007
-2% -$1.17M 1.39% 5
2016
Q4
$72.3M Sell
490,896
-64,653
-12% -$9.36M 1.41% 4
2016
Q3
$70.2M Buy
555,549
+13,365
+2% +$1.61M 1.32% 8
2016
Q2
$61.1M Buy
542,184
+2,798
+0.5% +$290K 1.26% 8
2016
Q1
$56.1M Buy
539,386
+18,338
+4% +$1.75M 1.24% 8
2015
Q4
$58.8M Sell
521,048
-10,676
-2% -$1.18M 1.38% 4
2015
Q3
$58.2M Sell
531,724
-36,368
-6% -$3.89M 1.39% 6
2015
Q2
$54.3M Sell
568,092
-10,850
-2% -$1.01M 1.24% 11
2015
Q1
$53.9M Sell
578,942
-478
-0.1% -$41.8K 1.23% 11
2014
Q4
$47.5M Buy
579,420
+11,960
+2% +$917K 1.13% 19
2014
Q3
$36.4M Buy
567,460
+6,154
+1% +$377K 0.96% 37
2014
Q2
$34.1M Buy
561,306
+29,148
+5% +$1.72M 0.86% 44
2014
Q1
$31.9M Sell
532,158
-4,985
-0.9% -$307K 0.85% 44
2013
Q4
$34.2M Buy
537,143
+7,834
+1% +$504K 0.93% 40
2013
Q3
$36M Buy
529,309
+66,638
+14% +$4.76M 1.1% 25
2013
Q2
$33.3M Buy
+462,671
New +$30.6M 1.23% 14

Other funds holding ICUI

GW&K Investment Management's ICUI Position: Q1 2026 in Review

GW&K Investment Management reduced its ICU Medical (ICUI) stake by 32% in Q1 2026, selling an estimated $25.2K and leaving 370 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #570.

GW&K Investment Management first reported a position in ICUI in Q2 2013 and has held it in 52 quarters since. The position peaked at $124M in Q2 2018. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • GW&K Investment Management held 370 shares of ICU Medical worth $48K as of Q1 2026.
  • GW&K Investment Management sold 175 ICU Medical shares in Q1 2026, an estimated $25.2K.
  • ICU Medical made up ﹤0.01% of GW&K Investment Management's portfolio in Q1 2026, its #570 holding.
  • GW&K Investment Management first reported a position in ICU Medical in Q2 2013 and has held it in 52 quarters since.
  • GW&K Investment Management's ICU Medical position peaked at $124M in Q2 2018.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.